In September 2011, Eli Lilly and Company launched the Lilly NCD Partnership, a $30 million investment over five years to fight the rising burden of non-communicable diseases (NCDs) in developing countries. NCDs are by far the leading cause of death in the world. Of the 57 million global deaths in 2008, 63 percent were due to NCDs. Eighty percent of all NCD deaths occur in low- and middle-income countries. These chronic diseases—including diabetes, cancer, and heart disease—take lives, destroy opportunity, cause poverty, thwart development, and weaken communities. The partnership are currently working in health organizations in Brazil, India, Mexico and South Africa—countries that suffer a large burden of NCDs—to develop effective, efficient and sustainable programs that can meaningfully improve health outcomes for those in need.
|Location||Latin America and Caribbean, India, Brazil, South Asia, South Africa, Southern Africa|
|Value||USD 30 Million|